Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease prostate cancer
Phenotype C0011849|diabetes mellitus
Sentences 14
PubMedID- 25995760 Several other factors, including altered leptin concentrations, the use of medications such as statins and metformin, and changes in diet and lifestyle in order to control diabetes, have also been implicated in biological mechanisms behind the decreased risk of prostate cancer in patients with diabetes mellitus [70, 71].
PubMedID- 22413038 People tend to consume more animal foods and less plants, and the prevalence of obesity, cardiovascular diseases, diabetes mellitus, along with prostate cancer and breast cancer have increased during that time [10,11].
PubMedID- 21070583 diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the prostate cancer outcomes study.
PubMedID- 21562753 Objective: to analyze the association of diabetes mellitus (dm) with risk of prostate cancer and cancer grade among men undergoing prostate biopsy and to analyze how obesity and race modify these associations.
PubMedID- 20219288 Are microvascular complications of diabetes mellitus really associated with prostate cancer.
PubMedID- 26559055 Although most studies conducted in western countries suggest a lower risk of prostate cancer in patients with type 2 diabetes mellitus [13], studies conducted in taiwan and china do not conclude similarly and on the contrary support a higher risk of prostate cancer in patients with type 2 diabetes mellitus in terms of incidence [14,15], prevalence [16] and mortality [17].
PubMedID- 20956995 Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy.
PubMedID- 24761863 Purpose: the aim of this study to analyze the association between history of diabetes mellitus (dm) with risk of prostate cancer (pca) and cancer grade among men undergoing radical prostatectomy for pca.
PubMedID- 25066306 Besides, diabetes mellitus was also associated with prostate cancer-specific mortality (hazard ratio = 1.26, 95% confidence interval = 1.20-1.33) and nonprostate cancer mortality (hazard ratio = 1.83, 95% confidence interval = 1.33-2.52) separately.
PubMedID- 24412228 Patient summary: in this trial we assessed the use of the diabetes mellitus drug metformin in patients with advanced prostate cancer.
PubMedID- 21415239 Patients and methods: records of consecutive prostate cancer patients with coexisting diabetes mellitus type 2 who were treated at the study institution between 15 july 1999 and 31 december 2008 were reviewed.
PubMedID- 22019035 We evaluated whether there is an independent association between diabetes mellitus and the risk of high grade prostate cancer in men diagnosed with prostate cancer and treated with radiation therapy.
PubMedID- 22656412 Objective: to investigate the association of diabetes mellitus (dm) with prostate cancer (pca) risk and grade among japanese patients undergoing extended biopsy and to investigate how obesity modifies these relationships.
PubMedID- 20473853 Association of diabetes mellitus with prostate cancer: nested case-control study (prostate testing for cancer and treatment study).

Page: 1